These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 35052981)
1. Crumbling the Castle: Targeting DNABII Proteins for Collapsing Bacterial Biofilms as a Therapeutic Approach to Treat Disease and Combat Antimicrobial Resistance. Rogers JV; Hall VL; McOsker CC Antibiotics (Basel); 2022 Jan; 11(1):. PubMed ID: 35052981 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies that target extracellular DNABII proteins or the type IV pilus of nontypeable Jurcisek JA; Hofer LK; Goodman SD; Bakaletz LO Biofilm; 2022 Dec; 4():100096. PubMed ID: 36532267 [TBL] [Abstract][Full Text] [Related]
3. ESKAPEE pathogens newly released from biofilm residence by a targeted monoclonal are sensitized to killing by traditional antibiotics. Kurbatfinski N; Kramer CN; Goodman SD; Bakaletz LO Front Microbiol; 2023; 14():1202215. PubMed ID: 37564292 [TBL] [Abstract][Full Text] [Related]
4. A Humanized Monoclonal Antibody Potentiates Killing of Diverse Biofilm-Forming Respiratory Tract Pathogens by Antibiotics. Kurbatfinski N; Goodman SD; Bakaletz LO Antimicrob Agents Chemother; 2022 Mar; 66(3):e0187721. PubMed ID: 35007137 [TBL] [Abstract][Full Text] [Related]
5. Targeting a bacterial DNABII protein with a chimeric peptide immunogen or humanised monoclonal antibody to prevent or treat recalcitrant biofilm-mediated infections. Novotny LA; Goodman SD; Bakaletz LO EBioMedicine; 2020 Sep; 59():102867. PubMed ID: 32651162 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the kinetics and mechanism of action of anti-integration host factor-mediated disruption of bacterial biofilms. Brockson ME; Novotny LA; Mokrzan EM; Malhotra S; Jurcisek JA; Akbar R; Devaraj A; Goodman SD; Bakaletz LO Mol Microbiol; 2014 Sep; 93(6):1246-58. PubMed ID: 25069521 [TBL] [Abstract][Full Text] [Related]
7. DNABII proteins play a central role in UPEC biofilm structure. Devaraj A; Justice SS; Bakaletz LO; Goodman SD Mol Microbiol; 2015 Jun; 96(6):1119-35. PubMed ID: 25757804 [TBL] [Abstract][Full Text] [Related]
8. Natural antigenic differences in the functionally equivalent extracellular DNABII proteins of bacterial biofilms provide a means for targeted biofilm therapeutics. Rocco CJ; Davey ME; Bakaletz LO; Goodman SD Mol Oral Microbiol; 2017 Apr; 32(2):118-130. PubMed ID: 26988714 [TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies against DNA-binding tips of DNABII proteins disrupt biofilms in vitro and induce bacterial clearance in vivo. Novotny LA; Jurcisek JA; Goodman SD; Bakaletz LO EBioMedicine; 2016 Aug; 10():33-44. PubMed ID: 27342872 [TBL] [Abstract][Full Text] [Related]
10. Biofilms can be dispersed by focusing the immune system on a common family of bacterial nucleoid-associated proteins. Goodman SD; Obergfell KP; Jurcisek JA; Novotny LA; Downey JS; Ayala EA; Tjokro N; Li B; Justice SS; Bakaletz LO Mucosal Immunol; 2011 Nov; 4(6):625-37. PubMed ID: 21716265 [TBL] [Abstract][Full Text] [Related]
11. Alternatives to Conventional Antibiotic Therapy: Potential Therapeutic Strategies of Combating Antimicrobial-Resistance and Biofilm-Related Infections. Xu Q; Hu X; Wang Y Mol Biotechnol; 2021 Dec; 63(12):1103-1124. PubMed ID: 34309796 [TBL] [Abstract][Full Text] [Related]
12. Micro/nanosystems and biomaterials for controlled delivery of antimicrobial and anti-biofilm agents. Bianchera A; Buttini F; Bettini R Expert Opin Ther Pat; 2020 Dec; 30(12):983-1000. PubMed ID: 33078643 [TBL] [Abstract][Full Text] [Related]
13. Antibodies against the DNABII protein integration host factor (IHF) inhibit sinus implant biofilms. Martyn L; Sethia R; Chon R; Novotny L; Goodman SD; Elmaraghy C; Bakaletz LO Laryngoscope; 2020 Jun; 130(6):1364-1371. PubMed ID: 31314141 [TBL] [Abstract][Full Text] [Related]
14. Immunization with a Biofilm-Disrupting Nontypeable Bailey MT; Lauber CL; Novotny LA; Goodman SD; Bakaletz LO mSphere; 2020 Apr; 5(2):. PubMed ID: 32295873 [TBL] [Abstract][Full Text] [Related]
15. Biofilm exacerbates antibiotic resistance: Is this a current oversight in antimicrobial stewardship? Bowler P; Murphy C; Wolcott R Antimicrob Resist Infect Control; 2020 Oct; 9(1):162. PubMed ID: 33081846 [TBL] [Abstract][Full Text] [Related]
16. Targeting the HUβ Protein Prevents Porphyromonas gingivalis from Entering into Preexisting Biofilms. Rocco CJ; Bakaletz LO; Goodman SD J Bacteriol; 2018 Jun; 200(11):. PubMed ID: 29437850 [TBL] [Abstract][Full Text] [Related]
17. Enzymatic dispersion of biofilms: An emerging biocatalytic avenue to combat biofilm-mediated microbial infections. Ramakrishnan R; Singh AK; Singh S; Chakravortty D; Das D J Biol Chem; 2022 Sep; 298(9):102352. PubMed ID: 35940306 [TBL] [Abstract][Full Text] [Related]
19. Nanobiotics and the One Health Approach: Boosting the Fight against Antimicrobial Resistance at the Nanoscale. Himanshu ; Mukherjee R; Vidic J; Leal E; da Costa AC; Prudencio CR; Raj VS; Chang CM; Pandey RP Biomolecules; 2023 Jul; 13(8):. PubMed ID: 37627247 [TBL] [Abstract][Full Text] [Related]
20. Antibodies directed against integration host factor mediate biofilm clearance from Nasopore. Brandstetter KA; Jurcisek JA; Goodman SD; Bakaletz LO; Das S Laryngoscope; 2013 Nov; 123(11):2626-32. PubMed ID: 23670606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]